Safety and Efficacy of SC101 Via Perirenal Fat Injection for Resistant Hypertension in Patients With Moderate to Severe Chronic Kidney Disease
Clinical trial NCT07483372 · RECRUITING
Trial details
- NCT number
- NCT07483372
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-27
- Primary completion
- 2027-12-31
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.